Pelvic Organ Prolapse (POP) is a disabling and chronic condition that affects a rough 20% of women ranging in all ages [1]. Pelvic organs can protrude outside the body through the vagina due to weakness in the pelvic floor. POP affects patients both physically and psychologically. Most women with POP suffer from at least one other pelvic floor disorder, such as incontinence. Pelvic Organ Prolapse increasing nationwide, namely, anterior, posterior and middle compartments prolapse. Plenty of different kits have been created.
{"title":"Ureteral Stenosis after Uterine Suspension Using TVM (Transvaginal Mesh)","authors":"Hun‐Shan Pan, Wei-Jiun Li, Masumoto Ko, Yan-Fong Lu, K. Pan, C.J. Pan, Jier-Zen Chang, Lee‐Wen Huang","doi":"10.33552/WJGWH.2019.02.000535","DOIUrl":"https://doi.org/10.33552/WJGWH.2019.02.000535","url":null,"abstract":"Pelvic Organ Prolapse (POP) is a disabling and chronic condition that affects a rough 20% of women ranging in all ages [1]. Pelvic organs can protrude outside the body through the vagina due to weakness in the pelvic floor. POP affects patients both physically and psychologically. Most women with POP suffer from at least one other pelvic floor disorder, such as incontinence. Pelvic Organ Prolapse increasing nationwide, namely, anterior, posterior and middle compartments prolapse. Plenty of different kits have been created.","PeriodicalId":87379,"journal":{"name":"World journal of gynecology & womens health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48257441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-04-18DOI: 10.33552/WJGWH.2019.02.000533
A. A. Al-Rukeimi
{"title":"Assessment of Bacterial Contamination at the Time of Embryo Transfer, and its Impression on the In-VitroFertilization / Pregnancy Outcome, in Sana’a City, Yemen","authors":"A. A. Al-Rukeimi","doi":"10.33552/WJGWH.2019.02.000533","DOIUrl":"https://doi.org/10.33552/WJGWH.2019.02.000533","url":null,"abstract":"","PeriodicalId":87379,"journal":{"name":"World journal of gynecology & womens health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41741613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-04-18DOI: 10.33552/WJGWH.2019.02.000534
B. Petrikovsky
In 1954 and 1956, Deanesly [1] and Green, et al. [2] were one of the first to experiment with the freezing and thawing of animal ovarian tissue. In the first half of the 20th century, the art of tissue cryopreservation was at its infancy with glycerol being the only cryoprotectant available [3]. Glycerol is a poor cryoprotectant and, therefore, early research showed very limited success [4]. Additional cryoprotectants became available during the 1990s leading to successful ovarian tissue cryopreservation, transplantation, and resumption of fertility studies in animals and humans [3,5,6].
{"title":"An Established Technology Gets a New Application: Reimplantation of Autologous Ovarian Tissue to Treat Menopausal Symptoms","authors":"B. Petrikovsky","doi":"10.33552/WJGWH.2019.02.000534","DOIUrl":"https://doi.org/10.33552/WJGWH.2019.02.000534","url":null,"abstract":"In 1954 and 1956, Deanesly [1] and Green, et al. [2] were one of the first to experiment with the freezing and thawing of animal ovarian tissue. In the first half of the 20th century, the art of tissue cryopreservation was at its infancy with glycerol being the only cryoprotectant available [3]. Glycerol is a poor cryoprotectant and, therefore, early research showed very limited success [4]. Additional cryoprotectants became available during the 1990s leading to successful ovarian tissue cryopreservation, transplantation, and resumption of fertility studies in animals and humans [3,5,6].","PeriodicalId":87379,"journal":{"name":"World journal of gynecology & womens health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44721572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-03-18DOI: 10.33552/WJGWH.2019.02.000531
J. Bardos
This work is licensed under Creative Commons Attribution 4.0 License WJGWH.MS.ID.000531. Abstract Purpose: To identify population-specific carrier frequencies for Citrullinemia Type 1. Better knowledge of population specific carrier frequencies improves carrier testing and genetic counseling; however, prior reports have not captured data in specific ethnic groups. Identifying a fetus at risk for CTLN1 could allow prenatal planning by arranging for appropriate post-partum care to mitigate or prevent long lasting neurological damage with prompt use of metabolic therapy.
{"title":"Carrier Rate of Citrullinemia, Type I in Individual Ethnic Groups Using an Expanded Carrier Test","authors":"J. Bardos","doi":"10.33552/WJGWH.2019.02.000531","DOIUrl":"https://doi.org/10.33552/WJGWH.2019.02.000531","url":null,"abstract":"This work is licensed under Creative Commons Attribution 4.0 License WJGWH.MS.ID.000531. Abstract Purpose: To identify population-specific carrier frequencies for Citrullinemia Type 1. Better knowledge of population specific carrier frequencies improves carrier testing and genetic counseling; however, prior reports have not captured data in specific ethnic groups. Identifying a fetus at risk for CTLN1 could allow prenatal planning by arranging for appropriate post-partum care to mitigate or prevent long lasting neurological damage with prompt use of metabolic therapy.","PeriodicalId":87379,"journal":{"name":"World journal of gynecology & womens health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49302316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-03-15DOI: 10.33552/WJGWH.2019.02.000530
Mohamed Mutasim Mohamed Ahamed
{"title":"Dichorionic Twin Pregnancy Discordant for Fetal Anencephaly: A Case Report","authors":"Mohamed Mutasim Mohamed Ahamed","doi":"10.33552/WJGWH.2019.02.000530","DOIUrl":"https://doi.org/10.33552/WJGWH.2019.02.000530","url":null,"abstract":"","PeriodicalId":87379,"journal":{"name":"World journal of gynecology & womens health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44326848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-03-08DOI: 10.33552/WJGWH.2019.02.000529
T. Mohamed
{"title":"An Evaluation of Ovarian Response and Pregnancy Rates with the Use of Growth Hormone as an Adjunct to IVF in Women who are Poor Responders to Standard IVF Stimulation Protocols","authors":"T. Mohamed","doi":"10.33552/WJGWH.2019.02.000529","DOIUrl":"https://doi.org/10.33552/WJGWH.2019.02.000529","url":null,"abstract":"","PeriodicalId":87379,"journal":{"name":"World journal of gynecology & womens health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47566149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-03-01DOI: 10.33552/wjgwh.2019.02.000528
Yi-Liang Lee
{"title":"The Office Vaginoscopic Hysteroscopy in Management of Virginal Women with Recurrent Abnormal Uterine Bleeding","authors":"Yi-Liang Lee","doi":"10.33552/wjgwh.2019.02.000528","DOIUrl":"https://doi.org/10.33552/wjgwh.2019.02.000528","url":null,"abstract":"","PeriodicalId":87379,"journal":{"name":"World journal of gynecology & womens health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43996687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-02-27DOI: 10.33552/wjgwh.2019.02.000527
M. Corigliano, Pizzicaroli Caterina, Larciprete Giovanni
{"title":"Congenital Heart Block in Lupus Erythematosus Syndrome and Anti Ro-SSA Antibodies. A Case Report","authors":"M. Corigliano, Pizzicaroli Caterina, Larciprete Giovanni","doi":"10.33552/wjgwh.2019.02.000527","DOIUrl":"https://doi.org/10.33552/wjgwh.2019.02.000527","url":null,"abstract":"","PeriodicalId":87379,"journal":{"name":"World journal of gynecology & womens health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41700559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-02-20DOI: 10.33552/WJGWH.2019.02.000526
L. S. Bezerra, M. Santos-Veloso, S. G. Lima
Cardiovascular diseases are a major cause of maternal mortality and morbidity worldwide, including developed countries [1]. The first-line drug to treat hypertension in pregnant women is methyldopa, which is an α2-adrenergic agent that has shown maternal and fetal safety and efficacy. However, methyldopa is not effective in all cases, and sometimes it is important to consider other pharmacological agents [1,2].
{"title":"Chronic Hypertension During the First Trimester of Pregnancy: What is New About the Use of Angiotensin-Converting Enzyme Inhibitors?","authors":"L. S. Bezerra, M. Santos-Veloso, S. G. Lima","doi":"10.33552/WJGWH.2019.02.000526","DOIUrl":"https://doi.org/10.33552/WJGWH.2019.02.000526","url":null,"abstract":"Cardiovascular diseases are a major cause of maternal mortality and morbidity worldwide, including developed countries [1]. The first-line drug to treat hypertension in pregnant women is methyldopa, which is an α2-adrenergic agent that has shown maternal and fetal safety and efficacy. However, methyldopa is not effective in all cases, and sometimes it is important to consider other pharmacological agents [1,2].","PeriodicalId":87379,"journal":{"name":"World journal of gynecology & womens health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47152071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：